Pre-operative
Pre-discharge
1 to 3 months
Pre-operative to Pre-discharge; Pre- to 3-months
B. Moderate LV dysfunction (LVEF > 35%) (N=28)
LV EF (%) 47 ± 7 39 ± 11 41 ± 14 p=0.62; p=0.25
LV EDVI (mL/m²) 78 ± 20 70 ± 25 57 ± 28 p=0.06; p=0.01
LV ESVI (mL/m²) 43 ± 12 41 ± 15 36 ± 22 p=0.06; p=0.01
LV global longitudinal strain (%) -10 ± 3 -10 ± 5 -9 ± 3 p=0.74; p=0.18
LV circumferential strain (%) -15 ± 6 -16 ± 9 -14 ± 6 p=0.84; p=0.75
LV radial strain (%) 6 ± 6 4 ± 8 6 ± 6 p=0.22; p=1.0
Regurgitant orifice area (cm²) 0.53 ± 0.52 N/A N/A N/A
PASP (mmHg) 47 ± 17 46 ± 17 34 ± 12 p=0.22; p=0.01
RV FAC (%) 29 ± 5 33 ± 7 35 ± 8 p=0.01; p=0.01
RVFWLS (%) -15 ± 5 -18 ± 7 -18 ± 8 p=0.62; p=0.36
RVS’ 7.9 ± 2.8 9.0 ± 3.0 9.0 ± 2.9 p=0.69; p=0.16
TAPSE (cm) 1.4 ± 0.4 1.5 ± 0.4 1.5 ± 0.4 p=0.65; p=0.26